Topol noted that "there is no evidence from randomized trials in humans that any of these peptides provide the benefits that are advocated," and the same evidence gap applies in reverse to long-horizon harms
Retatrutide, Multi Agonist Obesity Drugs, and the PBM Access War Lilly Bets $8B on Weight Loss Future The Next Two Weeks in GLP1 Are Huge, Here's Why He Took Retatrutide 40mg and Proved a Point This episode examines a serious case involving retatrutide, where an individual experienced an overdose due to improper medication administration
The most frequent symptom of muscle palmitoyltransferase CPT II deficiency is an exercise induced myalgia [1]
Children with this condition may develop dark-colored spots on the mouth, lips, eyes, nose, hands, and feet
In the landmark SELECT trial in 2023, the scope of GLP-1RAs was expanded to assess cardiovascular risk in patients with preexisting cardiovascular disease who were overweight or obese without type 2 diabetes [48]